1. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling. Issue 8 (11th June 2021) Authors: Yu, Jiang; Chen, Wen‐XU; Xie, Wen‐Jing; Chen, Rong‐Wei; Lin, Dan‐Qi; You, Wei‐Wei; Ye, Wei‐Lin; Zhang, Hong‐Qin; Lin, Dong‐Hong; Xu, Jian‐Ping Journal: Journal of clinical laboratory analysis Issue: Volume 35:Issue 8(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗